Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK Trial Neal D. Shore , Martin Gleave , Ugo De Giorgi +16 more NCT02319837. 2025 The Journal of Urology 0 citations